Filing Details

Accession Number:
0001144204-13-066827
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-12 06:06:36
Reporting Period:
2013-12-11
Filing Date:
2013-12-12
Accepted Time:
2013-12-12 06:06:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1038977 S Michael Weiss 787 Seventh Avenue, 48Th Floor
New York NY 10019
See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-11 10,000 $3.43 7,839,471 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 2,236,743 shares of restricted Common Stock, which vest on various time and market capitalization targets. Includes 33,334 warrants to purchase Common Stock at $2.25, exercisable through December 31, 2016. Finally, also included in Mr. Weiss' beneficial ownership are 4,524,560 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.